Type 2 VWD is characterized by a qualitatively deficient VWF showing decreased VWF activity/VWF antigen (VWF:Ag) or factor VIII clotting factor activity (FVIII:C)/VWF:Ag. This evidence concerns the gene VWF and von Willebrand disease 2.